3 Lessons Learned from Pandemic-Era Clinical Development Regulatory Practices
HIT Consultant
AUGUST 18, 2021
The pandemic has given rise to new norms in drug development that will influence the future of the industry as we know it. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools. Since March 2020, the FDA has issued 72 new COVID-specific guidance documents and is likely to continue.
52 
Let's personalize your content